EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?

Claire Murphy iD, Adam H Dyer iD, Brian Lawlor, Sean P Kennelly, NILVAD study group

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0285529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Claire Murphy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Age-Related Healthcare, Tallaght University Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Alzheimer Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In addition to the clear cardiovascular benefit, there has been renewed interest in the potential of statins in the prevention of cognitive impairment and dementia in older adults. However, whether ongoing statin use can delay cognitive decline or dementia progression in those with established Alzheimer dementia, is unclear.

Methods

Using data from NILVAD, we analysed the association between ongoing statin use and cognitive decline (Alzheimer Disease Assessment Scale-Cognitive Subsection [ADAS-Cog])/dementia progression (Clinical Dementia Rating Scale [CDR-Sb]/Disability Assessment for Dementia [DAD]) over 18 months in older adults with mild-moderate AD. Additionally, we assessed the association between ongoing statin use and adverse events in mild-moderate AD.

Results

Over one-third (34.9%) of 510 older adults with mild-moderate AD (aged: 72.9 years; 61.9% female) used a statin for the 18-month study duration. Statin use was not associated with the rate of cognitive decline (β: -0.67; 95% CI: -1.71, 0.36, p = 0.20) or dementia progression (β: -0.34; 95% CI -0.71, 0.02; p = 0.07 for CDR-Sb/ β: -2.00; -5.70, 1.70; p = 0.29 for DAD). Further, ongoing statin use was not associated with adverse events, serious adverse events, unscheduled GP visits, or unscheduled hospitalisation.

Conclusion

Ongoing statin use was not associated with cognitive decline or dementia progression in mild-moderate AD. Similarly, use was not associated with adverse events including abnormal liver function tests or falls. Whilst safe in those with AD, the current results suggest ongoing statin use does not delay cognitive decline or clinical progression in established AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsCognitive DysfunctionFemaleHumansAgedMaleLongitudinal StudiesMental Status and Dementia TestsDisease Progression

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Age-Related Healthcare, Tallaght University Hospital, Dublin, Ireland.
  • Department of Medical Gerontology, School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

ORCID-Profile: Claire Murphy, Adam H Dyer

Zitieren

APA

Murphy, C., Dyer, A. H., Lawlor, B., Kennelly, S. P., & NILVAD study group (2023). What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?. PLOS ONE. https://doi.org/10.1371/journal.pone.0285529

Vancouver

Murphy C, Dyer AH, Lawlor B, Kennelly SP, NILVAD study group. What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?. PLOS ONE. 2023. doi:10.1371/journal.pone.0285529

BibTeX
@article{Murphy2023,
  author = {Murphy, Claire and Dyer, Adam H and Lawlor, Brian and Kennelly, Sean P and NILVAD study group, NILVAD study group},
  title = {What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0285529}
}
Kostenlos starten →